POXEL.PA WACC - Weighted Average Cost of Capital
The WACC of Poxel SA (POXEL.PA) is 8.2%.
| Range | Selected | |
| Cost of equity | 6.3% - 12.6% | 9.45% |
| Tax rate | 0.0% - 0.0% | 0% |
| Cost of debt | 7.0% - 7.7% | 7.35% |
| WACC | 6.7% - 9.6% | 8.2% |
| Category | Low | High |
| Long-term bond rate | 3.0% | 3.5% |
| Equity market risk premium | 5.8% | 6.8% |
| Adjusted beta | 0.56 | 1.27 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.3% | 12.6% |
| Tax rate | 0.0% | 0.0% |
| Debt/Equity ratio | 1.54 | 1.54 |
| Cost of debt | 7.0% | 7.7% |
| After-tax WACC | 6.7% | 9.6% |
| Selected WACC | 8.2% | |
| Debt/Equity | Unlevered | |||
| Peers | Company Name | ratio | Beta | beta |
| POXEL.PA | Poxel SA | 1.54 | -0.64 | -0.25 |
| ALBPS.PA | Biophytis SA | 2.64 | 0.52 | 0.14 |
| BINV.ST | BioInvent International AB | 0.01 | 0.57 | 0.56 |
| FARN.L | Faron Pharmaceuticals Oy | 0.05 | 0.14 | 0.13 |
| GNFT.PA | Genfit SA | 0.37 | 1.48 | 1.08 |
| HPHA.DE | Heidelberg Pharma AG | 0.1 | 0.76 | 0.69 |
| ORY.MC | Oryzon Genomics SA | 0.05 | 0.57 | 0.54 |
| OSE.PA | Ose Immunotherapeutics SA | 0.4 | 0.95 | 0.68 |
| SANION.ST | Saniona AB | 0.01 | -0.34 | -0.34 |
| TILS.L | Tiziana Life Sciences PLC | 0.01 | -1.34 | -1.34 |
| Low | High | |
| Unlevered beta | 0.14 | 0.55 |
| Relevered beta | 0.34 | 1.4 |
| Adjusted relevered beta | 0.56 | 1.27 |
POXEL.PA's CAPM model and how its cost of Equity is calculated
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for POXEL.PA:
cost_of_equity (9.45%) = risk_free_rate (3.25%) + equity_risk_premium (6.30%) * adjusted_beta (0.56) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.